AP-15000

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAP-15000
Drug Alias NameAP-15000
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIsarna Therapeutics Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIsarna Therapeutics Gmbh
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A